Umoja BioPharma
Latest round
- Series C
Last raised
- Oct 2024
Total raised
- $363M
Investors
- 18
About Umoja BioPharma
Established in 2019 and based in Washington, US, Umoja BioPharma, Inc. operates as a biopharmaceutical company. The company was founded by its CEO, Dr. Andrew Scharenberg, CTO, Dr. Ryan Crisman, and Scientific Advisory Board Co-Chairs Michael Jensen and Philip Low. In January 2025, Umoja BioPharma, Inc. Umoja BioPharma develops integrated cellular immunotherapy that helps in treating tumors through retooling a patient's immune system. The company has two lead pipeline programs under its portfolio: TumorTag UB-TT170 and VivoVec UB-VV100. TumorTag UB-TT170 is used for controlling folate receptors expressing solid tumors, and VivoVec UB-VV100 is being developed to treat patients with CD19+ hematological cancers.
Who invested in Umoja BioPharma
18 investors across 4 rounds
See all investors in Umoja BioPharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Umoja BioPharma
Who invested in Umoja BioPharma?
Umoja BioPharma has 18 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Umoja BioPharma raised?
Umoja BioPharma has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Umoja BioPharma last raise money?
Umoja BioPharma's most recent round on record is a Series C, in Oct 2024.
What does Umoja BioPharma do?
Established in 2019 and based in Washington, US, Umoja BioPharma, Inc.
Where is Umoja BioPharma headquartered?
Umoja BioPharma is headquartered in Seattle, US.
Which VCs invest in companies like Umoja BioPharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Umoja BioPharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Umoja BioPharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.